Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remote Double-Blind Randomized Placebo-Controlled Phase 3 Study of Rotigotine Patch in Adolescents With Idiopathic Restless Legs Syndrome
2018-001445-13Phase 3
- Sponsor
- UCB
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in restless legs syndrome (RLS) comparing Rotigotine transdermal patch with Placebo patch (2 arms). Primary endpoint: Change in IRLS sum score from baseline to end of maintenance.
02
Drugs
rotigotine
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on 2018-001445-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001445-13.